|
Market Closed -
Australian S.E.
20:00:15 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 0.2400 AUD | 0.00% |
|
+2.13% | -28.36% |
| 08-25 | Compumedics Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-25 | Compumedics Fiscal 2026 EBITDA, Revenue Up | MT |
Company Valuation: Compumedics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 69.98 | 59.35 | 48.97 | 47.94 | - | - |
| Change | - | - | -17.49% | -2.1% | - | - |
| Enterprise Value (EV) | 69.98 | 59.35 | 48.97 | 47.94 | 47.94 | 47.94 |
| Change | - | - | -17.49% | -2.1% | 0% | 0% |
| P/E | 65.8x | -335x | -36.4x | 255x | 11.4x | 7.5x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | -0x | -2x | 0x | 0.1x |
| Capitalization / Revenue | 1.96x | - | 0.96x | 0.85x | 0.63x | 0.53x |
| EV / Revenue | 0x | - | 0x | 0.8x | 0.63x | 0.53x |
| EV / EBITDA | 0x | - | 0x | 9.78x | 5.33x | 3.93x |
| EV / EBIT | 0x | - | 0x | 18.4x | 7.38x | 4.99x |
| EV / FCF | -0x | - | -0x | -36.9x | 15x | 8.56x |
| FCF Yield | -0.33% | - | -13.7% | 5.3% | 6.67% | 11.7% |
| Dividend per Share 2 | - | - | - | - | 0.02 | 0.028 |
| Rate of return | - | - | - | - | 8.33% | 11.7% |
| EPS 2 | 0.006 | -0.001 | -0.007 | 0.001 | 0.021 | 0.032 |
| Distribution rate | - | - | - | - | 95.2% | 87.5% |
| Net sales 1 | 35.74 | - | 50.96 | 60.25 | 75.6 | 91 |
| EBITDA 1 | 2.563 | - | 2.938 | 5.37 | 9 | 12.2 |
| EBIT 1 | 1.106 | - | 0.692 | 3.172 | 6.5 | 9.6 |
| Net income 1 | 0.998 | -0.499 | -1.272 | 0.214 | 6 | 9.2 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 0.3950 | 0.3350 | 0.2550 | 0.2400 | 0.2400 | 0.2400 |
| Nbr of stocks (in thousands) | 177,163 | 177,163 | 192,039 | 199,762 | - | - |
| Announcement Date | 8/26/21 | 8/30/24 | 8/26/25 | 8/24/26 | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.29x | - | - | -.--% | 33.67M | |
| 33.55x | 5.86x | 22.46x | 0.27% | 250B | |
| 37.86x | 6.77x | 21.47x | 0.63% | 158B | |
| 43.91x | 11.62x | 25.64x | -.--% | 143B | |
| 16.61x | 3.4x | 11.09x | -.--% | 63.65B | |
| 34.1x | 6.82x | 21.58x | -.--% | 49.74B | |
| 33.66x | 6.66x | 22.6x | 0.59% | 48.71B | |
| 18.61x | 2.27x | 11.47x | 2.71% | 47.94B | |
| 75.9x | 7.23x | 22.05x | -.--% | 42.59B | |
| 54.59x | 8.79x | 31.04x | -.--% | 40.77B | |
| Average | 38.31x | 6.60x | 21.04x | 0.42% | 84.4B | |
| Weighted average by Cap. | 37.18x | 6.93x | 21.68x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CMP Stock
- Valuation Compumedics Limited
Select your edition
All financial news and data tailored to specific country editions
